Manager, Real World Evidence
Florida Cancer Specialists & Research Institute
Oncology Drug Crash Course: Teclistamab-cqyv (Tecvayli)
Amanda Warner, MS, BSN, RN, OCN, who is manager of research informatics & real world evidence with Florida Cancer Specialists & Research Institute, provides an in-depth look at teclistamab in a downloadable fact sheet.
Cabozantinib Combo Maintains PFS for Advanced RCC at Follow-Up
Nivolumab Plus Cabozantinib Effective Long-Term for Advanced RCC
High PSA Levels Before HIFU May Increase Recurrence Risk in Intermediate-Risk Prostate Cancer
Enfortumab Vedotin and Pembrolizumab Effective in Treating Primary UTUC Lesions